Exact Mass: 393.088

Exact Mass Matches: 393.088

Found 33 metabolites which its exact mass value is equals to given mass value 393.088, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Homidium bromide

Homidium bromide

C21H20N3. Br (393.0841)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D004396 - Coloring Agents > D005456 - Fluorescent Dyes D004791 - Enzyme Inhibitors

   

Q-100035

19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione

C20H15N3O6 (393.0961)


   

Rubitecan

(19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione

C20H15N3O6 (393.0961)


Rubitecan is a pyranoindolizinoquinoline that is camptothecin in which the hydrogen at position 9 has been replaced by a nitro group. It is a prodrug for 9-aminocamptothecin. It has a role as an antineoplastic agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor and a prodrug. It is a pyranoindolizinoquinoline, a C-nitro compound, a semisynthetic derivative, a tertiary alcohol and a delta-lactone. Rubitecan is a semisynthetic agent related to camptothecin with potent antitumor and antiviral properties. Rubitecan binds to and inhibits the enzyme topoisomerase I and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells; this agent also prevents repair of reversible single-strand DNA breaks. (NCI04) C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors Rubitecan (RFS 2000), a Camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells[1][2][3].

   

3,5-bis(Acetyloxy)-2-(1,3-benzothiazol-2-yl)tetrahydro-2H-pyran-4-yl acetate

3,5-bis(Acetyloxy)-2-(1,3-benzothiazol-2-yl)tetrahydro-2H-pyran-4-yl acetate

C18H19NO7S (393.0882)


   
   

10-nitro camptothecin

10-nitro camptothecin

C20H15N3O6 (393.0961)


   
   
   
   

CAY10571

4-[5-(4-fluorophenyl)-2-[4-9methylsulfonyl)phenyl]-1H-imidazol-4-yl]-pyridine

C21H16FN3O2S (393.0947)


   
   

9-nitro-20(S)-camptothecin

9-nitro-20(S)-camptothecin

C20H15N3O6 (393.0961)


Annotation level-1

   

9-nitrocamptothecin

9-nitrocamptothecin

C20H15N3O6 (393.0961)


   

3-Butyl-1,1,2-trimethyl-1H-benz[e]indolium iodide

3-Butyl-1,1,2-trimethyl-1H-benz[e]indolium iodide

C19H24IN (393.0953)


   

Rosiglitazone HCl

Rosiglitazone HCl

C18H20ClN3O3S (393.0914)


Rosiglitazone (BRL 49653) hydrochloride is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone hydrochloride is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone hydrochloride can be used in the research of obesity and diabetes, senescence, ovarian cancer[1][2][4][7].

   
   

Codeine methylbromide

Codeine methylbromide

C19H24BrNO3 (393.0939)


   

4-chloro-N-[2-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide

4-chloro-N-[2-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide

C18H20ClN3O3S (393.0914)


   

N-[3-chloro-4-[(1S,2R,6S,7R)-3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]phenyl]pyridine-2-carboxamide

N-[3-chloro-4-[(1S,2R,6S,7R)-3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]phenyl]pyridine-2-carboxamide

C21H16ClN3O3 (393.088)


   

3-{[(2,2-Dioxido-1,3-dihydro-2-benzothien-5-YL)amino]methylene}-5-(1,3-oxazol-5-YL)-1,3-dihydro-2H-indol-2-one

3-{[(2,2-Dioxido-1,3-dihydro-2-benzothien-5-YL)amino]methylene}-5-(1,3-oxazol-5-YL)-1,3-dihydro-2H-indol-2-one

C20H15N3O4S (393.0783)


   

4-[4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-1H-imidazol-5-yl]pyridine

4-[4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-1H-imidazol-5-yl]pyridine

C21H16FN3O2S (393.0947)


   

5-Ethyl-3-imino-6-phenylphenanthridin-8-amine;hydrobromide

5-Ethyl-3-imino-6-phenylphenanthridin-8-amine;hydrobromide

C21H20BrN3 (393.0841)


   

Homidium bromide

Homidium bromide

C21H20BrN3 (393.0841)


D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D004396 - Coloring Agents > D005456 - Fluorescent Dyes D004791 - Enzyme Inhibitors

   

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-4-methoxybenzamide

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-4-methoxybenzamide

C17H13F6NO3 (393.08)


   

2-[[5,6-Bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-1-(4-methoxyphenyl)ethanone

2-[[5,6-Bis(2-furanyl)-1,2,4-triazin-3-yl]thio]-1-(4-methoxyphenyl)ethanone

C20H15N3O4S (393.0783)


   

8-Methoxy-6-nitro-3-[oxo-(2-phenyl-4,5-dihydroimidazol-1-yl)methyl]-1-benzopyran-2-one

8-Methoxy-6-nitro-3-[oxo-(2-phenyl-4,5-dihydroimidazol-1-yl)methyl]-1-benzopyran-2-one

C20H15N3O6 (393.0961)


   

3-chloro-4-ethoxy-N-[3-(2-oxazolo[5,4-b]pyridinyl)phenyl]benzamide

3-chloro-4-ethoxy-N-[3-(2-oxazolo[5,4-b]pyridinyl)phenyl]benzamide

C21H16ClN3O3 (393.088)


   

2-[(3-cyano-4-phenyl-6-thiophen-2-yl-2-pyridinyl)thio]-N-propan-2-ylacetamide

2-[(3-cyano-4-phenyl-6-thiophen-2-yl-2-pyridinyl)thio]-N-propan-2-ylacetamide

C21H19N3OS2 (393.0969)


   

N-[(E)-[5-(2-nitrophenyl)furan-2-yl]methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

N-[(E)-[5-(2-nitrophenyl)furan-2-yl]methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide

C20H15N3O6 (393.0961)


   

(2S)-2-(3-chlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)propanamide

(2S)-2-(3-chlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)propanamide

C21H16ClN3O3 (393.088)


   

7,19-dichloro-3,10-dimethyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),4,6,8,11,14,17,19,21-nonaene

7,19-dichloro-3,10-dimethyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),4,6,8,11,14,17,19,21-nonaene

C22H17Cl2N3 (393.0799)


   

(2r)-3-{[(1-hydroxy-3-methoxy-7-methyl-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-{[(1-hydroxy-3-methoxy-7-methyl-5,8-dioxonaphthalen-2-yl)methyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

C18H19NO7S (393.0882)


   

(2s,10r)-7,19-dichloro-3,10-dimethyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),4,6,8,11,14,17,19,21-nonaene

(2s,10r)-7,19-dichloro-3,10-dimethyl-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),4,6,8,11,14,17,19,21-nonaene

C22H17Cl2N3 (393.0799)